Matthais Peltz, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dallas, TXNPI 1073717856
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,054 of the $9,572 with a category attached, or 73.7%. Transmedics, Inc. accounts for 65.3% of it on its own, with 8 other manufacturers making up the rest.
Across 37 payments — averaging $258.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$6K
- Medtronic$965
- Abbott$807
- Xvivo Perfusion Inc.$663
- Edwards Lifesciences$321
- Kerecis Limited$286
- plus $279 from 3 others
Across 67 payments — averaging $4016.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$120K
- Xvivo Perfusion Inc.$103K
- Abbott$46K
What the payments were for
- Travel & lodging$7,05474%
- Food & beverage$2,51926%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 6 | $6,252 |
| Medtronic | 7 | $965 |
| Abbott | 10 | $807 |
| Xvivo Perfusion Inc. | 3 | $663 |
| Edwards Lifesciences | 3 | $321 |
| Kerecis Limited | 2 | $286 |
| Abiomed | 4 | $251 |
| Pylant Medical | 1 | $16 |
| Atricure, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,572 in reported general payments places this provider in the 60th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 21 | $6,989 |
| Nystatin | 12 | $632 |
| Pantoprazole Sodium | 37 | $174 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $162 |
| Rosuvastatin Calcium | 12 | $97 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Dallas
- Robert HebelerDallas$723K
- Michael WaitDallas$187K
- Juan MachannafordDallas$164K
- Aldo Rafael-YarihuamanDallas$142K
- Todd DeweyDallas$128K
- Gary SchwartzDallas$77K
- Jaye WestonDallas$70K
- Brandon HillDallas$53K
- Ryan DaviesDallas$51K
- Dan MeyerDallas$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.